G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake

Abstract

More selective interactions of nanoparticles with cells would substantially increase their potential for diagnostic and therapeutic applications. Thus, it would not only be highly desirable that nanoparticles can be addressed to any cell with high target specificity and affinity, but that we could unequivocally define whether they rest immobilized on the cell surface as a diagnostic tag, or if they are internalized to serve as a delivery vehicle for drugs. To date no class of targets is known that would allow direction of nanoparticle interactions with cells alternatively into one of these mutually exclusive events. Using MCF-7 breast cancer cells expressing the human Y 1 -receptor, we demonstrate that G protein-coupled receptors provide us with this option. We show that quantum dots carrying a surface-immobilized antagonist remain with nanomolar affinity on the cell surface, and particles carrying an agonist are internalized upon receptor binding. The receptor functions like a logic "and-gate" that grants cell access only to those particles that carry a receptor ligand "and" where the ligand is an agonist. We found that agonist-and antagonistmodified nanoparticles bind to several receptor molecules at a time. This multiligand binding leads to five orders of magnitude increased-receptor affinities, compared with free ligand, in displacement studies. More than 800 G protein-coupled receptors in humans provide us with the paramount advantage that targeting of a plethora of cells is possible, and that switching from cell recognition to cell uptake is simply a matter of nanoparticle surface modification with the appropriate choice of ligand type.nanoparticle targeting | drug delivery | quantum dots | nanoparticle receptor interaction | cell membrane binding

Exploring aspects of cell intelligence with artificial reaction networks

“…In other work, Stadtman and Chock (1997) demonstrated that such a network can act as a flexible computational unit. Similar results were documented by Arkin and Ross (1994), and recently a number of researchers have developed these ideas (Hild et al 2010;Wang 2011).…”

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

“…This activity can alter the fate of NPs decorated with such peptides [273]. In this study, the targeting of quantum dots to G protein-coupled receptors using peptide agonists led to the internalization of the nanomaterial.…”

Biocompatibility assessment of functionalized magnetic mesoporous silica nanoparticles in human HepaRG cells

“…According to Cerdevall et al, the corona could alter biological functions by the high presence of proteins in a restricted cellular area (Cedervall et al 2007). Thereby, this complex may appear to the cell as an exogenous compound, leading to a recognition by G protein-coupled receptors, integrins, and Toll-like transmembrane receptors, acting as gateways to the cell and triggering the proinflammatory response (Hild et al 2010). Thus, due to the presence of a protein corona around them, NPs may 'mislead' the cells, which may recognize these NPs as pathogen-like invaders, such as lipopolysaccharides (LPS) originating from bacterial outer membranes.…”